Sign in
4/A

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-009724

Director bought 194,445 shares at $18.00 ($3,500,010)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Belldegrun Arie Director 2018-10-15 Purchase +194,445 $18.00 $3,500,010 1,691,781 I: show line 1 in the form
Open-market purchases · 194,445 sh · avg $18.00 · $3,500,010
Loading xslF345X03/doc4a.xml…